发明名称 |
COMPOSITION |
摘要 |
Compound (I), and pharmaceutically acceptable salts thereof, are inducers of human interferon. Certain discrete and particular dosages of Compound (I) may be particularly useful in the treatment of various disorders, for example the treatment of allergic diseases and other inflammatory conditions, for example allergic rhinitis and allergic asthma.; |
申请公布号 |
US2014288099(A1) |
申请公布日期 |
2014.09.25 |
申请号 |
US201214234070 |
申请日期 |
2012.07.19 |
申请人 |
Ambery Claire Louise;Edwards Christopher David |
发明人 |
Ambery Claire Louise;Edwards Christopher David |
分类号 |
C07D473/28 |
主分类号 |
C07D473/28 |
代理机构 |
|
代理人 |
|
主权项 |
1. A pharmaceutical dosage form comprising Compound (I): or a pharmaceutically acceptable salt thereof, and means for providing a metered-dose of Compound (I), or a pharmaceutically acceptable salt thereof. |
地址 |
Uxbridge GB |